GoodRx hits milestone for diabetes
By HME News Staff
Updated 8:20 PM CDT, Tue August 15, 2023
SANTA MONICA, Calif. - GoodRx says it has helped almost 2.5 million Americans save more than $500 million on diabetes treatments to date. The company says, for example, that its customers saved, on average, 37% on continuous glucose monitors, including the Dexcom G6 and G7, FreeStyle Libre, Libre 2 and Libre 3. “Managing a chronic condition can be incredibly expensive and time consuming – so much so, we’ve seen the cost of supplies and prescriptions used to manage diabetes impact which treatment plan patients opt for,” said Karla Robinson, MD, medical editor at GoodRx. “By providing incredible savings and information in one place, GoodRx is an invaluable resource for those living with diabetes to help them more easily access and afford the proper treatment they need.” While there are recent efforts to curb the prices of insulin, GoodRx Research shows the average cash price for insulin rose 54% from 2014-19 and only decreased 7.1% from 2020-23. There’s a significant economic burden that comes with a diabetes diagnosis, the company says, with costs potentially exceeding $5,800 per year when factoring in medications, doctor visits, outpatient care and self-care to control blood glucose levels.
Comments